000184633 001__ 184633
000184633 005__ 20190812205655.0
000184633 022__ $$a1107-3756
000184633 02470 $$2ISI$$a000310651600099
000184633 037__ $$aCONF
000184633 245__ $$aAnti-glycan antibodies in epithelial ovarian cancer
000184633 260__ $$bSpandidos Publ Ltd$$c2012$$aAthens
000184633 269__ $$a2012
000184633 300__ $$a1
000184633 336__ $$aConference Papers
000184633 700__ $$uUniv Basel Hosp, Gynecol Res Grp, Dept Biomed, CH-4031 Basel, Switzerland$$aJacob, Francis
000184633 700__ $$0243936$$g151741$$aGoldstein, Darlene
000184633 700__ $$uUniv Zurich Hosp, Translat Res Grp, CH-8091 Zurich, Switzerland$$aPochechueva, Tatiana
000184633 700__ $$uUNSW, Ovarian Canc Grp, Lowy Canc Res Ctr, Sydney, NSW, Australia$$aTse, Brian W. C.
000184633 700__ $$uRAS, Shemyakin Oschinnikov Ist Bioorgan Chem, Moscow 117901, Russia$$aBovin, Nicolai V.
000184633 700__ $$uGlycoMed Res Inst, New York, NY USA$$aHufleji, Marget E.
000184633 700__ $$aHacker, Neville H.
000184633 700__ $$aHeinzelmann-Schwarz, Viola$$uUniv Basel Hosp, Gynecol Res Grp, Dept Biomed, CH-4031 Basel, Switzerland
000184633 773__ $$j30$$tInternational Journal Of Molecular Medicine$$qS29-S29
000184633 909C0 $$xU10124$$pSTAT$$0252136
000184633 909CO $$pconf$$pSB$$ooai:infoscience.tind.io:184633
000184633 917Z8 $$x111184
000184633 937__ $$aEPFL-CONF-184633
000184633 973__ $$rREVIEWED$$sPUBLISHED$$aEPFL
000184633 980__ $$aCONF